Constipation during GLP-1 treatment: a safe conversation guide
Constipation is a common reported effect of GLP-1 and related medicines. In the label’s adult weight-reduction trials, 24% of people on Wegovy injection reported it versus 11% on placebo, and 11% to 17% on Zepbound (by dose) versus 5% on placebo. The Wegovy Medication Guide says to tell your healthcare provider if you have stomach problems that are severe or will not go away. The Zepbound label also lists ileus and severe constipation among events reported after approval.
Sources checked against Europe PMC abstracts and FDA/DailyMed label text: Nov 17, 2026; full text not read for abstract-only claims (recheck on publication date)
Quick answer
Constipation is a common reported effect of GLP-1 and related medicines. In the label’s adult weight-reduction trials, 24% of people on Wegovy injection reported it versus 11% on placebo, and 11% to 17% on Zepbound (by dose) versus 5% on placebo. The Wegovy Medication Guide says to tell your healthcare provider if you have stomach problems that are severe or will not go away. The Zepbound label also lists ileus and severe constipation among events reported after approval.
How common is it?

Constipation in trials
The numbers come from separate trial programs in adults with obesity or overweight, so they should not be used to rank the products. Sources: Wegovy label, Table 3; Zepbound label, Table 1.
What the labels say about serious cases
The Zepbound label lists, among gastrointestinal events reported after approval, ileus (a stalled bowel), intestinal obstruction, and severe constipation including fecal impaction. It notes these reports come from a population of uncertain size, so frequency and cause cannot be reliably estimated. Both Wegovy and Zepbound are not recommended in severe gastroparesis. The Wegovy Medication Guide says to tell your provider if you have stomach problems that are severe or will not go away.
What to bring to the conversation
- When the constipation started relative to the first dose or a dose change.
- How often you are passing stool, and any change from your usual.
- Pain, bloating, vomiting, or inability to pass gas or stool.
- What you eat and drink, how much fluid, and your activity.
- All medicines and supplements, since other medicines can cause constipation.
Self-care suggestions
Two kinds of source apply here. Neither is a label instruction.
GLP-1-specific expert advice. The 2025 joint advisory from four U.S. nutrition and obesity societies (consensus for clinicians, not a trial) says constipation is common with weight loss and should be managed proactively. Source 4.
- Encourage enough fluids and fiber from food.
- Raise fiber gradually, for example with prunes or other dried fruit.
- Foods high in protein or fat slow stomach emptying, which can worsen constipation, so a clinician may suggest limiting them temporarily.
- Some anti-nausea medicines can worsen constipation.
- Options a clinician may consider include magnesium citrate, fiber supplements and polyethylene glycol 3350.
A 2022 multidisciplinary expert consensus on GI adverse events of GLP-1 medicines gives recommendations for clinicians and patients on limiting nausea, vomiting, diarrhea and constipation. Its details are not summarized here. Source 5.
General constipation guidance. The 2023 American College of Gastroenterology and American Gastroenterological Association guideline covers chronic idiopathic constipation, not constipation caused by medicines. It reviewed fiber, osmotic and stimulant laxatives and other agents, and made strong recommendations for several of them, including polyethylene glycol. Source 6. Fiber works best with enough fluids and can cause gas.
Which product, if any, is right for you depends on your health and your other medicines, so ask your clinician or pharmacist before starting one. Do not use this page to pick a laxative or a dose.
What this does not establish
Trial figures describe groups and do not predict your experience. Constipation has many causes besides medication. This page does not diagnose a cause or recommend treatment.
FAQs
Can a GLP-1 medicine cause constipation? Yes. It was reported more often than with placebo in label trials.
When should I contact my clinician? The Wegovy Medication Guide says to tell your healthcare provider about stomach problems that are severe or will not go away. For emergencies, call your local emergency number.
What can I try at home? Fluids, fiber from food, and movement are the common starting points in the sources above. Check with your care team before adding supplements or laxatives.
What details should I share? Timing, stool pattern, symptoms, diet and fluids, and all medicines.
Sources
- FDA label, Wegovy
- FDA label, Zepbound
- Wegovy Medication Guide, DailyMed
- Nutritional priorities to support GLP-1 therapy for obesity: joint advisory, Am J Clin Nutr 2025
- Clinical recommendations to manage GI adverse events with GLP-1 receptor agonists: multidisciplinary expert consensus (2022), PMC9821052
- ACG-AGA clinical practice guideline on chronic idiopathic constipation, 2023, PMC10544839